New cancer drug enters first human trials for advanced tumors
NCT ID NCT05653882
Summary
This is the first human study testing a new cancer drug called AB248, either alone or combined with an existing immunotherapy (pembrolizumab). The trial aims to find safe doses and see if the treatment shows early signs of helping adults with advanced solid tumors that have spread or cannot be removed by surgery. Researchers will carefully monitor side effects and how the drug behaves in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Intermountain Health
Murray, Utah, 84107, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
NYU
New York, New York, 10016, United States
-
Ocala Oncology Center
Ocala, Florida, 34474, United States
-
Providence Cancer Institute Franz Clinic
Portland, Oregon, 97213, United States
-
Rutgers
New Brunswick, New Jersey, 08901, United States
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
UCLA
Los Angeles, California, 90095, United States
-
UCSD
San Diego, California, 92037, United States
-
UCSF
San Francisco, California, 94143, United States
-
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27599, United States
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
-
University of Miami
Miami, Florida, 33136, United States
-
Virginia Commonwealth
Richmond, Virginia, 23298, United States
-
Washington University
St Louis, Missouri, 63110, United States
-
Yale
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.